Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein.

Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein.

T cells are central to immunity in malaria. CD4+ helper T cells favour the generation of high-affinity antibodies that are effective against blood stages and they are necessary to establish immunological memory. The intrahepatic stage of infection can be eliminated by specific CD8+ cytotoxic T cells...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Plebanski, M, Lee, E, Hill, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	1997

Documenti analoghi

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.
di: Plebanski, M, et al.
Pubblicazione: (1999)

Malaria oocysts require circumsporozoite protein to evade mosquito immunity
di: Feng Zhu, et al.
Pubblicazione: (2022-06-01)

Sterile protection against malaria is independent of immune responses to the circumsporozoite protein.
di: Anne Charlotte Grüner, et al.
Pubblicazione: (2007-12-01)

Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity
di: Liriye Kurtovic, et al.
Pubblicazione: (2021-12-01)

Naturally exposed populations differ in their T1 and T2 responses to the circumsporozoite protein of Plasmodium falciparum.
di: Reece, W, et al.
Pubblicazione: (2002)

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
di: Atcheson, E, et al.
Pubblicazione: (2020)

Blood Stage Malaria Disrupts Humoral Immunity to the Pre-erythrocytic Stage Circumsporozoite Protein
di: Gladys J. Keitany, et al.
Pubblicazione: (2016-12-01)

Circumsporozoite Surface Protein-based malaria vaccines: a review
di: Maria Edilene Martins de Almeida, et al.
Pubblicazione: (2021-01-01)

An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein
di: Lucie Jelínková, et al.
Pubblicazione: (2021-01-01)

Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a geographical bias
di: Saralamba, N, et al.
Pubblicazione: (2018)

Cellular immune response of humans to the circumsporozoite protein of Plasmodium vivax
di: Mauricio M. Rodrigues, et al.
Pubblicazione: (1991-06-01)

Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a geographical bias
di: Naowarat Saralamba, et al.
Pubblicazione: (2018-07-01)

ATG Ubiquitination Is Required for Circumsporozoite Protein to Subvert Host Innate Immunity Against Rodent Malaria Liver Stage
di: Hong Zheng, et al.
Pubblicazione: (2022-02-01)

Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
di: Cate Speake, et al.
Pubblicazione: (2016-01-01)

A model to study the impact of polymorphism driven liver-stage immune evasion by malaria parasites, to help design effective cross-reactive vaccines
di: Kirsty Lee Wilson, et al.
Pubblicazione: (2016-03-01)

Correction: Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
di: C Speake, et al.
Pubblicazione: (2016-01-01)

Design and Evaluation of Chimeric <i>Plasmodium falciparum</i> Circumsporozoite Protein-Based Malaria Vaccines
di: William H. Stump, et al.
Pubblicazione: (2024-03-01)

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection
di: Kelly E. Seaton, et al.
Pubblicazione: (2021-08-01)

Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
di: Mohammad Zeeshan, et al.
Pubblicazione: (2012-01-01)

The altered membrane of malaria-infected erythrocytes: variable epitopes and immune evasion/conserved epitopes and cytoadherence
di: Russell J. Howard, et al.
Pubblicazione: (1986-01-01)

Prevalence and level of antibodies to the circumsporozoite protein of human malaria parasites in five states of the Amazon region of Brazil
di: Mercia E Arruda, et al.
Pubblicazione: (2007-06-01)

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.
di: Reece, W, et al.
Pubblicazione: (2004)

Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.
di: Marcela Parra, et al.
Pubblicazione: (2015-01-01)

A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
di: Tan, J, et al.
Pubblicazione: (2018)

Altered peptide ligands: prospects for immune intervention in autoimmune disease.
di: Fairchild, P
Pubblicazione: (1997)

Altered peptide ligands: Prospects for immune intervention in autoimmune disease
di: Fairchild, P
Pubblicazione: (1997)

Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
di: Nouh Saad Mohamed, et al.
Pubblicazione: (2021-11-01)

Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population.
di: Kwadwo A Kusi, et al.
Pubblicazione: (2020-01-01)

Protective Malaria Vaccine in Mice Based on the <i>Plasmodium vivax</i> Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein
di: Rodolfo F. Marques, et al.
Pubblicazione: (2020-04-01)

Immune Evasion Strategies of Pre-Erythrocytic Malaria Parasites
di: Hong Zheng, et al.
Pubblicazione: (2014-01-01)

Monoclonal Antibodies against Plasmodium falciparum Circumsporozoite Protein
di: Min Zhang, et al.
Pubblicazione: (2017-08-01)

The immunology of malaria infection.
di: Plebanski, M, et al.
Pubblicazione: (2000)

False positive circumsporozoite protein ELISA: a challenge for the estimation of the entomological inoculation rate of malaria and for vector incrimination
di: Trung Ho Dinh, et al.
Pubblicazione: (2011-07-01)

Evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals
di: Hodgson, SH, et al.
Pubblicazione: (2014)

Structure of the trypanosome transferrin receptor reveals mechanisms of ligand recognition and immune evasion
di: Trevor, C, et al.
Pubblicazione: (2019)

A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
di: Erwan Atcheson, et al.
Pubblicazione: (2021-04-01)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals.
di: Hodgson, S, et al.
Pubblicazione: (2014)

Genetic polymorphism and evidence of signatures of selection in the Plasmodium falciparum circumsporozoite protein gene in Tanzanian regions with different malaria endemicity
di: Beatus M. Lyimo, et al.
Pubblicazione: (2024-05-01)

The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial.
di: Régine Audran, et al.
Pubblicazione: (2009-10-01)

Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.
di: Kavita Gandhi, et al.
Pubblicazione: (2014-01-01)